Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 2 , ISSUE 4 ( October-December, 2008 ) > List of Articles

RESEARCH ARTICLE

Three-dimensional Ultrasound in the Fertility Clinic

Shilpa Deb, Zeina Haoula, Nick Raine-Fenning

Keywords : Three-dimensional,ultrasound,ovarian reserve,reproductive medicine,gynecology,endometrial receptivity

Citation Information : Deb S, Haoula Z, Raine-Fenning N. Three-dimensional Ultrasound in the Fertility Clinic. Donald School J Ultrasound Obstet Gynecol 2008; 2 (4):65-74.

DOI: 10.5005/jp-journals-10009-1079

License: CC BY-NC 4.0

Published Online: 01-12-2008

Copyright Statement:  Copyright © 2008; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

The management of subfertility involves a detailed assessment of the couple to identify factors that may affect or predict the outcome of treatment. Three-dimensional imaging is one of the recent advances in the field of ultrasound which has several obvious benefits that relate to an improved spatial orientation and the demonstration of additional image planes such as the coronal plane. Many clinicians remain unconvinced by its reputed advantages and three-dimensional ultrasound is not without disadvantages. These mainly relate to the cost involved and training requirements. Threedimensional ultrasound imaging is still at a relatively early stage in terms of its role as a day-to-day imaging modality in gynecology and reproductive medicine. Other than its application in the assessment and differentiation of uterine anomalies there is little evidence that three-dimensional ultrasound results in clinically-relevant benefit or negates the need for further investigation. Future work should ensure that three-dimensional ultrasound is compared to conventional imaging in randomized trials where the observer is blinded to the outcome such that its role in reproductive medicine can be truly evaluated in an evidence-based manner.


PDF Share
  1. Women's awareness and perceptions of delay in childbearing. Fertil Steril 2008;90(4):1036-42.
  2. Accuracy of three-dimensional ultrasound in diagnosis and classification of congenital uterine anomalies. Fertil Steril 2008.
  3. Three-dimensional ultrasonography in gynecology: Technical aspects and clinical applications. J Ultrasound Med 2003;22(11):1249-69.
  4. A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod 2003;18(1):162-66.
  5. Three-dimensional ultrasound for the assessment of uterine anatomy and detection of congenital anomalies: A comparison with hysterosalpingography and twodimensional sonography. Ultrasound Obstet Gynecol 1995;5(4):233-37.
  6. Congenital Mullerian anomalies: Diagnostic accuracy of three-dimensional ultrasound. Fertil Steril 1996; 65(3): 523-28.
  7. Detection of congenital mullerian duct anomalies using three-dimensional ultrasound. J Clin Ultrasound 1997;25(9):487-92.
  8. Clinical implications of sonographic detection of uterine anomalies for reproductive outcome. Ultrasound Obstet Gynecol 2001;18(4):387-400.
  9. The septate uterus: A review of management and reproductive outcome. Fertil Steril 2000; 73(1):1-14.
  10. Reproductive outcomes in women with congenital uterine anomalies detected by three-dimensional ultrasound screening. Obstet Gynecol 2001;98(6):1099-103.
  11. Ultrasound screening for congenital uterine anomalies. Br J Obstet Gynaecol 1997;104(11):1320-21.
  12. Population-based study of the incidence of mullerian aplasia in Finland. Fertil Steril 2001;76(3):624-25.
  13. Transvaginal sonographic evaluation of endometrial polyps: A comparison with two-dimensional and three-dimensional contrast sonography. Clin Exp Obstet Gynecol 1999;26(3-4):171-73.
  14. Contrast sonography for uterine cavity assessment: A comparison of conventional two-dimensional with three-dimensional transvaginal ultrasound; a pilot study. Fertil Steril 1996;66(5):848-50.
  15. The value of transvaginal sonography with and without saline instillation in the diagnosis of uterine pathology in pre-and postmenopausal women with abnormal bleeding or suspect sonographic findings. Ultrasound Obstet Gynecol 1997;9(1):53-58.
  16. Three-dimensional multiplanar sonohysterography: Comparison with conventional twodimensional sonohysterography and X-ray hysterosalpingography. J Ultrasound Med 2001;20(4):295-306.
  17. Three-dimensional hysterosonography for the study of endometrial tumors: Comparison with conventional transvaginal sonography, hysterosalpingography, and hysteroscopy. Gynecol Oncol 1997;65(2):245-52.
  18. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: Results regarding the degree of intramural extension. Obstet Gynecol 1993;82(5):736-40.
  19. Fibroids and infertility: An updated systematic review of the evidence. Fertil Steril 2008.
  20. A prospective study to evaluate the efficacy of two-and three-dimensional sonohysterography in women with intrauterine lesions. Fertil Steril 2003;79(5):1222-25.
  21. Ultrasound in benign gynaecology Obstetrics, Gynaecology and Reproductive Medicine 2007;17(2):33-44.
  22. Three-dimensional ultrasonographic characteristics of endometriomata. Ultrasound Obstet Gynecol 2008;31(6):718-24.
  23. Laparoscopic treatment of benign ovarian tumors. Ginekol Pol 2006;77(1):40-47.
  24. Ultrasound assessment of the polycystic ovary: International consensus definitions. Hum Reprod Update 2003;9(6):505-14.
  25. Three-dimensional assessment of ultrasound features in women with clomiphene citrate-resistant polycystic ovarian syndrome (PCOS): Ovarian stromal volume does not correlate with biochemical indices. Hum Reprod 2002; 17(4):1052-55.
  26. Three-dimensional and power Doppler ultrasonography in infertility and reproductive endocrinology. Taiwan J Obstet Gynecol 2007;46(3):209-14.
  27. Treatment of hydrosalpinx in the patient undergoing assisted reproduction. Curr Opin Obstet Gynecol 2007; 19(4):360-65.
  28. Hydrosalpinx and IVF outcome: A prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod 1999;14(11):2762-69.
  29. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12(6):685-718.
  30. Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab 2007;18(2):58-65.
  31. Three-dimensional ultrasound improves the interobserver reliability of antral follicle counts and facilitates increased clinical work flow. Ultrasound Obstet Gynecol 2008; 31(4):439-44.
  32. Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment. Hum Reprod 2005;20(6): 1647-54.
  33. The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 2003;18(4):700-06.
  34. Regulation of ovarian follicular development in primates: Facts and hypotheses. Endocr Rev 1996;17(2):121-55.
  35. Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment? Hum Reprod 2007;22(7):1932-41.
  36. The interobserver reliability of ovarian volume measurement is improved with three-dimensional ultrasound, but dependent upon technique. Ultrasound Med Biol 2003;29(12):1685-90.
  37. Ovarian stromal vascularity is not predictive of ovarian response and pregnancy. Reprod Biomed Online 2006; 12(1):43-49.
  38. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review. Hum Reprod Update 2002;8(6):559-77.
  39. Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography. Fertil Steril 1998;70(4):671-75.
  40. Number and size of antral follicles as predictive factors in vitro fertilization and embryo transfer. J Assist Reprod Genet 2000;17(6):315-18.
  41. Ovarian morphology and serum hormone markers as predictors of ovarian follicle recruitment by gonadotropins for in vitro fertilization. J Clin Endocrinol Metab 2001;86(6):2538-43.
  42. Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age. Fertil Steril 2003;79(1):190-97.
  43. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril 2006;85(3):592-96.
  44. Antimullerian hormone serum levels: A putative marker for ovarian aging. Fertil Steril 2002;77(2):357-62.
  45. Serum level of anti-mullerian hormone in early follicular phase as a predictor of ovarian reserve and pregnancy outcome in assisted reproductive technology cycles. Arch Iran Med 2008;11(4): 371-76.
  46. Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J Clin Endocrinol Metab 2007;92(5):1796-802.
  47. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil Steril 2005; 83(4):979-87.
  48. The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: A critical review. Hum Reprod Update 1996; 2(4):323-35.
  49. Three-dimensional endometrial volume calculation and pregnancy rate in an in vitro fertilization programme. Hum Reprod 1999;14(5):1255-58.
  50. Role of three-dimensional ultrasonographic measurement of endometrium volume as a predictor of pregnancy outcome in an IVF-ET program: A preliminary study. Fertil Steril 2000;74(4):797-801.
  51. Assessment of endometrial volume by threedimensional ultrasound prior to embryo transfer: Clues to endometrial receptivity. Hum Reprod 1999;14(11):2851-54.
  52. Assessment of endometrial receptivity by transvaginal color Doppler and three-dimensional power Doppler ultrasonography in patients undergoing in vitro fertilization procedures. J Ultrasound Med 2001;20(2): 125-34.
  53. Detection of the subendometrial vascularization flow index by three-dimensional ultrasound may be useful for predicting the pregnancy rate for patients undergoing in vitro fertilization-embryo transfer. Fertil Steril 2003;79(3): 507-11.
  54. Quantitative assessment of subendometrial blood flow by three-dimensional-ultrasound is an important predictive factor of implantation in an in vitro fertilization programme. Hum Reprod 2000;15(1):89-94.
  55. The role of ovarian volume in an in vitro fertilization programme as assessed by 3D ultrasound. Arch Gynecol Obstet 2001;265(2):67-72.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.